Regenicin, Inc. (RGIN)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Feb 2, 2026
0.00%
Market Cap 15.35K
Revenue (ttm) n/a
Net Income (ttm) -985.39K
Shares Out 153.48M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,000
Average Volume 56,049
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0001
52-Week Range 0.0000 - 0.7501
Beta -46.21
RSI 47.02
Earnings Date n/a

About Regenicin

Regenicin, Inc. focuses on developing and commercializing the technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company's products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 3
Stock Exchange OTCMKTS
Ticker Symbol RGIN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.